BOSTON, Jan. 08, 2026 -- Aktis Oncology, Inc. (“Aktis”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed...
Art Pappas will speak on "Later Stage Venture Funding" at the University of North Carolina at Chapel Hill's Technology Commercialization Workshop in Chapel Hill.
News | 10. 21. 2010
